Iatrogenicity

IHOR GUSSAK, MD, PhD, FACC, is a clinical professor of medicine at the University of Medicine and Dentistry of New Jersey-Robert Wood Johnson, and executive editor of the Journal of Electrocardiology.JOHN B. KOSTIS, MD, FACP, FACC, is the John G. Detwiler Professor of Cardiology, professor of medicine and pharmacology, and associate dean for cardiovascular research at the University of Medicine and Dentistry of New Jersey. He is also the director of the Cardiovascular Institute at Robert Wood Johnson Medical School in New Brunswick, New Jersey.

• TABLE OF CONTENTSPart I: MEDICAL HARM 1.      The Concept and Spectrum of "Iatrogenicity" I. Gussak and J. Kostis2.      Iatrogenicity:  Definition, History and Modern Context M. Gussak, I. Gussak, and J. Kostis3.      Epidemiology and Public Health Aspects and Implications:  Regulatory, Legal and Ethical Dimensions of Iatrogenicity S. Jones and M. Gonzalez4.      Risk Management:  The Medical Center Administration Perspective S. Jones and M. Gonzalez5.      Iatrogenicity from the Patient's Perspective J. Dobrzynski, S. Jones, and M. Gonzalez6.      A Naturopathic Perspective on Iatrogenesis C. FleetwoodPart II:  IATROGENICITY OF CARDIOVASCULAR DURGS AND CARDIOVASCULAR TOXICITY OF NON-CARDIAC DRUGS 7.      Clinical Manifestations of Acute and Chronic Drug-Induced Iatrogenic Cardiovascular Diseases and Syndromes I. Gussak, G. Yan, A. Jahangir, and J. Kostis8.      Drug-Induced Cardiac Arrhythmias and Sudden Cardiac Death A. Narichania, Y. Yokoyama, and W.K. Shen9.      Chemotherapy-Induced Cardiomyopathies E. Birati and B. Jessup10.  Iatrogenicity of Blood Pressure Mesaurement in the Diagnosis of Hypertension T. Giles, G. Sander, I. Gussak, and J. Kostis11.  Antihypertensive Drug-Induced Iatrogenic Cardiovascular Syndromes R. Kalaitzidis and G. Bakris12.  Iatrogenicity of Cardiovascular Drugs Associated with Cardiac and Non-Cardiac Toxicities: Antihypertensive Agents and Biologics E. Hermes-Desantis and J. Barone13.  Iatrogenic Aspects of Hypertension in Pregnancy: Focus on Preeclampsia C. Thomopoulos and T. Makris14.  Women and Iatrogenic Cardiovascular Disease:  Menopausal Estrogen as the Prime Suspect G. Bachmann, M. Rees, and N. Phillips15.  Iatrogenic Aspects of Lipid-Lowering Agents, Thrombolytic, Antiplatelet, and Antithrombotic Agents C. Tsioufis, D. Konstantinidis, N. Vogiatzakis, and K. Dimitriadis16.  Iatrogenic Effects of ‘Urologic' Drugs on the Cardiovascular System K. Stavropoulos, C. Boutari, K. Imprialos, and M. Doumas17.  Iatrogencity and Antianginal Drugs A. Moreyra and W.J. Kostis18.  Anti-Diabetic Drugs and Cardiovascular Risk: Where Do We Stand? R. Kumar19.  Cardiovascular Iatrogenicity in Older Adults A. Khan, #. Ali, #. Iyengar, #. Hagiwara, #. Periyakoil, #. Patel, #. MalonePart III:  IATROGENCITY OF DIAGNOSTIC AND THERAPEUTIC, INVASIVE AND NON-INVASIVE CARDIOVASCULAR INTERVENTION, DEVICES, AND SURGERIES 20.  Iatrogenic Aspects of Non-Invasive and Invasive Diagnostic Methods in Interventional Cardiology C. DÖsch, D. Loßnitzer, T. Papavassiliu21.  Iatrogenicity Associated with Interventional Treatment Modalities N.V. Pothineni, A. Garg, H. Paydak, and J.L. Mehta22.  Iatrogenicity of Diagnostic and Therapeutic, Invasive and Non-Invasive Cardiovascular Interventions, Devices and Surgeries M. Behnes, T. Becher, S. Baumann, and I. Akin23.  Iatrogenic Aspects in Cardiac Electrophysiology B. Rudic, E. TÜlÜmen, and V. Liebe24.  Iatrogenic Aspects in Cardiac Device Therapy S. RÖger and J. Kuschyk25.  Cardiovascular Iatrogencity of Respiratory Therapeutic Modalities M.S. Nolledo, P. Lerma and T.V. SantiagoPart IV:  IATROGENIC ASPECTS OF SPORT CARDIOLOGY AND LIFE-STYLE MODIFICATIONS 26.  Professional Athletes G. Mancia27.  Sports Cardiology G. Campanile28.  Dangers of Lifestyle Modification Advice G. CampanilePart V:  IATROGENICITY OF DIETARY SUPPLEMENTS, HERBAL PRODUCTS, AND OTHER NON-TRADITIONAL THERAPIES IN CARDIOVASCULAR MEDICINE 29.  Safety of Over-the-Counter ‘Natural Substances’ and Vitamins:  Side-effects and Contraindications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. Jahangir30.  Interactions Between Supplements and Prescription Medications S. Sultan, A. Jahangir, C. Ding, H. Cao, J.B. Kostis, I.B. Gussak, and A. JahangirAcknowledgments Index